Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897270 · ClinicalTrials.gov registry record · NA
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
A NA study of Breast Carcinoma and Healthy Subject, sponsored by Roswell Park Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT03897270: Recruiting NA study of Breast Carcinoma and Healthy Subject, sponsored by Roswell Park Cancer Institute.
NCT03897270 is a NA study of Breast Carcinoma and Healthy Subject that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 400 participants, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03897270, a NA study of Breast Carcinoma and Healthy Subject, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more information about breast tissue.
Primary Outcome
Photoacoustic excitation and detection will be performed
Conditions Studied
Interventions
- PROCEDURE Photoacoustic Imaging
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2026-02-25 |
| Phase | NA |
What NCT03897270 shows while recruiting
NCT03897270 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Photoacoustic Imaging is the first listed.
NCT03897270 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03897270 about?
NCT03897270 is a clinical study titled "Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects". This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more in...
What is the current status of trial NCT03897270?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2018-10-25. Estimated completion is 2026-02-25.
What conditions does trial NCT03897270 study?
This clinical trial studies the following conditions: Breast Carcinoma, Healthy Subject.
What interventions are being tested in trial NCT03897270?
The interventions under investigation include: Photoacoustic Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT03897270?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03897270 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03897270's enrollment target sits among peer trials
400 25th of 106 higher than 81 of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
RECRUITING · NA
-
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
RECRUITING · NA
-
An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
RECRUITING · NA
-
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI